Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1970 Sep;40(1):92-101.
doi: 10.1111/j.1476-5381.1970.tb10614.x.

A comparison of the antinociceptive actions of cholinomimetic and morphine-like drugs

A comparison of the antinociceptive actions of cholinomimetic and morphine-like drugs

J D Ireson. Br J Pharmacol. 1970 Sep.

Abstract

1. The antinociceptive activity of morphine, nalorphine, oxotremorine and eserine has been examined in mice in electroshock and phenylbenzoquinone writhing tests.2. The effectiveness of these drugs alone, in combination with each other, and in combination with the muscarinic antagonist atropine sulphate, and with the narcotic antagonist naloxone has also been investigated.3. In both tests morphine was effective and antagonized by naloxone.4. Nalorphine was active in the phenylbenzoquinone test but only slightly active in the electroshock test: it was antagonized by naloxone in both tests.5. Morphine was potentiated by nalorphine in the phenylbenzoquinone test. but antagonized by it in the electroshock test.6. Oxotremorine was effective in both tests, and was antagonized by atropine sulphate.7. Eserine was active only in the phenylbenzoquinone test, and was antagonized by atropine sulphate.8. Oxotremorine was potentiated by eserine in the phenylbenzoquinone test, but antagonized by it in the electroshock test.9. Crossed agonist and partial agonist experiments produced enhancement.10. No antagonism was seen in the crossed antagonist experiments.11. The similarities between the effects of the two classes of drugs are discussed, and the conclusion drawn that they act by separate mechanisms.

PubMed Disclaimer

References

    1. J Pharm Pharmacol. 1969 Apr;21(4):248-50 - PubMed
    1. Int J Neuropharmacol. 1969 Sep;8(5):413-25 - PubMed
    1. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1962;242:414-29 - PubMed
    1. J Pharmacol Exp Ther. 1959 Mar;125(3):237-40 - PubMed

LinkOut - more resources